The increase in glucokinase and the decrease in glucose-6-phosphatase and PEPCK levels induced by STZ-induced diabetes were significantly improved in the BCS-treated groups (50, 100, and 200 mg/kg) (p < 0.01) (Table 7). This evidence concerns the gene G6PC1 and diabetes mellitus.